Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06398340

Identifying Wearable Biomarkers to Monitor Dietary Intake

Identifying Physiological Biomarkers for Monitoring Dietary Behaviours

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Background: Measuring what people eat is a challenge in nutrition research. Traditional methods, like food diaries, rely on self-reporting of individuals, and suffer from poor accuracy and recall bias. Aims: This project aims to identify physiological biomarkers related to food and energy intake, which may be used to develop an objective tool to estimate individuals' food intake in future. Eating behaviours are accompanied by significant physiological changes such as skin temperature, blood oxygen saturation, pulse rate etc. The investigators intend to investigate whether monitoring these physiological changes can help us estimate eating behaviour, such as meal size, eating speed, and duration of meals. Study design: Ten healthy adults will be invited for two study visits at NIHR Imperial Clinical Research Facility. Each visit will last for approximately 2 hr. They will consume a high- and low-calorie meal designed by nutritional researchers in a randomised order. During eating events, the investigators will track their physiological changes via a bedside monitor and wearable sensors. Blood samples will be taken from participants to measure their glycaemic response. Associations between energy load, glycaemic response, and physiological changes will be investigated. Our findings may promote an accelerated development of a wearable tool for dietary assessment in future.

Detailed description

1 Participants 10 healthy male and female participants. This is a pilot study in a new area and therefore a formal power calculation is not possible. 2\. Recruitment Participants will be recruited from existing healthy volunteer databases and by advertisement in public places. Adverts may be placed in newspapers and put up in public buildings. A contact number on the advert will enable potential participants to contact the research team at Imperial College London. Participation in the study will be entirely voluntary. No undue influence will be exerted by the researchers. Participants will be free to withdraw from the study at any time. 3 Pre-Screening Questionnaire A pre-screening questionnaire considering the inclusion and exclusion criteria will be completed to establish eligibility. For subjects who complete the questionnaire but do not continue to participate, their data will not be saved. 4 Informed Consent All participants will sign informed consent before starting the study (at the beginning of the 1st main study visit). 5 Main Study Visits Ten healthy subjects will attend two study visits at National Institute for Health and Care Research (NIHR) Imperial College London Clinical Research Facility (post code: W12 0NN, London, UK). The participants will consume a high- and low-calorie meal designed by nutritional researchers, in a randomised order. Randomization will be performed using the sealed envelope website by an independent researcher (i.e., not linked to the study). During eating events, physiological changes such as skin temperature, blood oxygen saturation, pulse rate etc and eating movements will be measured via a bedside monitor and non-invasive, wearable sensors. Blood samples will be taken at pre-determined time-points, starting 5 minutes before the meal and lasting for 60 minutes postprandially (at -5, +15, +30, +45, +60 min ). A total of 25 ml blood will be taken per visit.

Conditions

Interventions

TypeNameDescription
OTHERHigh Calorie Meal InterventionSubjects will receive a unhealthy meal high in calorie, sugar and fat
OTHERLow Calorie Meal InterventionSubjects will receive a healthy meal with balanced macronutrient, high in vegetables and dietary fibre

Timeline

Start date
2024-08-19
Primary completion
2025-06-30
Completion
2025-07-31
First posted
2024-05-03
Last updated
2025-02-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06398340. Inclusion in this directory is not an endorsement.